Recurrence · non‐pregnant women with a diagnosis of recurrent vulvovaginal candidiasis
It is very uncertain whether oral drug treatment changes primary outcome 2: Clinical recurrence at 12 months compared with topical drug treatment (very low certainty).
1 finding from 1 review
Primary outcome 3: Adverse events · non‐pregnant women with a diagnosis of recurrent vulvovaginal candidiasis
1 finding from 1 review
CAS improvement (decrease) by 2 or more points · thyroid‐associated ophthalmopathy
Summary of findings table ‐ Rituximab showed no clear difference in CAS improvement (decrease) by 2 or more points compared with intravenous methylprednisolone (low certainty).
1 finding from 1 review
NOSPECS improvement (decrease) by 2 classes or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes NOSPECS improvement (decrease) by 2 or more classes compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Proptosis improvement (decrease) by 2 mm or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes proptosis improvement (decrease) by 2 mm or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Palpebral aperture improvement (decrease) by 3 mm or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes palpebral aperture improvement (decrease) by 3 mm or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Motility improvement (increase) by 1 class or more · thyroid‐associated ophthalmopathy
It is very uncertain whether summary of findings table ‐ Rituximab changes motility improvement (increase) by 1 class or more compared with intravenous methylprednisolone (very low certainty).
1 finding from 1 review
Quality of life improvement by at least 6 points · thyroid‐associated ophthalmopathy
1 finding from 1 review
Adverse events · thyroid‐associated ophthalmopathy
Summary of findings table ‐ Rituximab showed no clear difference in adverse events compared with intravenous methylprednisolone (low certainty).
1 finding from 1 review
Positive birth experience (primary outcome)№ of participants: (0 studies) · pregnant women, multiparous, in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Spontaneous vaginal birth · pregnant women in labour at term
It is very uncertain whether routine vaginal examination changes spontaneous vaginal birth (primary outcome)№ of participants: 307(1… compared with routine rectal examination (very low certainty).
1 finding from 1 review
RR 0.98 [0.9, 1.06]
Studies not reported
Very low
Chorioamnionitis · pregnant women in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal infection · pregnant women in labour at term
It is very uncertain whether routine vaginal examination changes neonatal infection (primary outcome)№ of participants: 307(1 RCT) compared with routine rectal examination (very low certainty).
1 finding from 1 review
RR 0.33 [0.01, 8.07]
Studies not reported
Very low
Admission to neonatal intensive care unit · pregnant women in labour at term
It is very uncertain whether routine vaginal examination changes admission to neonatal intensive care unit№ of participants: 307(1 RCT) compared with routine rectal examination (very low certainty).
1 finding from 1 review
RR 1.32 [0.47, 3.73]
Studies not reported
Very low
Maternal pain (primary outcome)№ of participants: (0 studies) · pregnant women in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Positive birth experience (primary outcome)№ of participants: (0 studies) · primiparous pregnant women in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Augmentation of labour (primary outcome)№ of participants: (0 studies) · primiparous pregnant women in labour at term
It is very uncertain whether routine 4‐hourly vaginal examinations changes augmentation of labour (primary outcome)№ of participants: 109(1 RCT) compared with routine 2‐hourly vaginal examinations (very low certainty).
1 finding from 1 review
RR 0.97 [0.6, 1.57]
Studies not reported
Very low
Spontaneous vaginal birth · primiparous pregnant women in labour at term
It is very uncertain whether routine 4‐hourly vaginal examinations changes spontaneous vaginal birth (primary outcome)№ of participants: 150(1… compared with routine 2‐hourly vaginal examinations (very low certainty).
1 finding from 1 review
RR 1.02 [0.83, 1.26]
Studies not reported
Very low
Chorioamnionitis · primiparous pregnant women in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal infection · primiparous pregnant women in labour at term
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found